Skip to main content
Divisions Faculty General Pharmacotherapy and Experimental Therapeutics,
Grayson Mendenhall
August 24, 2015



Amber Proctor
Amber Proctor, Pharm.D., is a clinical oncology specialist at UNC Hospitals and an new instructor in the Division of Pharmacotherapy and Experimental Therapeutics. Hers is the first shared position between UNC Hospitals and DPET.

Amber Proctor, Pharm.D., has joined the UNC Eshelman School of Pharmacy as one of the newest members of the Division of Pharmacotherapy and Experimental Therapy. Proctor’s appointment is cofunded by UNC Hospitals, where she will also act as a clinical oncology specialist in thoracic oncology. Proctor began her appointment on August 1, 2015, after completing a PGY2 hematology and oncology pharmacy specialty residency at UNC Hospitals in June.

“I am thrilled that Amber Proctor is DPET’s first shared position with the UNC Medical Center,” said Angela Kashuba, Pharm.D., DPET chair and John and Deborah McNeill Jr. Distinguished Professor. “She will not only enrich our teaching mission but also help support the research bridge we have built between the bench and the bedside to improve patient care.”

At the hospital, Proctor will establish a pharmacy presence in the ambulatory oncology clinics for lung, sarcoma, head and neck and melanoma malignancies, she says. Hers is the first DPET position created in partnership with UNC Hospitals.

“I’ve always been passionate about teaching, and I chose to complete a clinical residency at UNC partly due to the numerous opportunities to collaborate with the UNC Eshelman School of Pharmacy,” Proctor says. “I am looking forward to familiarizing myself with the research interests of my fellow DPET members and helping establish and encourage further collaborative research projects with clinical practitioners at UNC Hospitals and other institutions.”

In her new role in DPET, Proctor will act as an instructor for part of the School’s Pharm.D. curriculum. Proctor will be co-coordinating PHYC 447, a hematology and oncology course for third-year pharmacy students, with William Zamboni, Pharm.D., Ph.D., in the fall and will be coordinating DPET 812, an oncology elective, in the spring, she says.

“I feel that it is important to continue to raise the bar in education and to produce health-care practitioners and researchers who are equipped to lead in finding solutions to health-care issues,” Proctor says.

Proctor earned her Doctor of Pharmacy from the Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Denver in 2013. She then came to UNC Hospitals to complete a PGY1 pharmacy residency and a PGY2 hematology and oncology pharmacy practice specialty residency.

 

Latest News


Comments are closed.